Jansen W
Med Klin. 1981 Aug 14;76(17):476-8.
25 geriatric patients with normal renal function and ten patients with impaired renal function were treated with piroxicam (Felden) for osteoarthritis of the major joints. The objective was to determine the efficacy and toleration of the drug and, in particular, renal parameters and--in the case of the patients with renal insufficiency--the plasma levels of the drug. Piroxicam improved both pain and restricted movement in both groups and it caused only few side effects. The specific laboratory values did not change in the patients with normal renal function, while renal parameters sometimes even improved in the patients with renal insufficiency during the treatment with piroxicam. Piroxicam did not accumulate in these patients despite the impaired renal function; the plasma levels corresponded to those found in patients with normal renal function.
25例肾功能正常的老年患者和10例肾功能受损的患者接受了吡罗昔康(费啶)治疗主要关节的骨关节炎。目的是确定该药物的疗效和耐受性,特别是肾脏参数,以及在肾功能不全患者中药物的血浆水平。吡罗昔康改善了两组患者的疼痛和活动受限情况,且仅引起很少的副作用。肾功能正常的患者特定实验室值未发生变化,而在使用吡罗昔康治疗期间,肾功能不全患者的肾脏参数有时甚至有所改善。尽管肾功能受损,但吡罗昔康在这些患者中并未蓄积;血浆水平与肾功能正常患者的水平相当。